Breye Therapeutics

EyeBio

This biotechnology company develops ocular therapies to treat retinal diseases such as diabetic macular edema and age-related macular degeneration for patients with vision loss.

Eyebiotech Limited

This clinical-stage biotechnology company develops therapies for retinal diseases, such as diabetic macular edema and age-related macular degeneration, to protect and restore patient vision.

Iveric Bio

This biopharmaceutical company develops therapeutic treatments for retinal diseases and provides these medicines to patients with age-related macular degeneration and inherited conditions.

Vantage Biosciences

This clinical-stage biotechnology company develops oral therapies to treat diabetic retinopathy and other inflammatory conditions for patients with diabetic eye disease.

Exonate

This biotechnology company develops non-invasive eye drops to treat patients with retinal vascular diseases such as diabetic retinopathy.

Eyexora

This company develops therapeutics and medical devices for ophthalmic diseases to treat patients with vision-threatening conditions.

Memento Medicines

This biotech company develops biologic therapies for retinal diseases to treat patients with neovascular age-related macular degeneration and diabetic macular edema.

Adverum Biotechnologies

The company develops ocular gene therapies to treat retinal diseases for patients with vision-threatening conditions such as wet age-related macular degeneration.